7 research outputs found
Recovery of the Rare Metals from Various Waste Ashes with the Aid of Temperature and Ultrasound Irradiation Using Chelants
A comparison of the acid mine drainage (AMD) neutralization potential of low grade nickel laterite and other alkaline-generating materials
Acid mine drainage (AMD) is a serious environmental problem caused by the weathering of sulfur-rich minerals found in mine sites, typically pyrite. Passive treatment methods have been extensively studied exploring various materials and treatment systems. Limestone is typically used as neutralizing media through open channels or anoxic limestone drains. However, the armouring that occurs when heavy metals precipitate on the surface restricts the lifespan of limestone treatment systems to 15-20 years. Goethite has been characterized to be a good adsorbent of heavy metals found in wastewater. It is abundant in a layer of nickel laterite deposit which are considered mine wastes due to the low amount of nickel present. This study investigates the performance of locally available nickel laterite ore rock, limestone, fly ash, and cement waste as media for AMD neutralization. The treatment efficiency are evaluated based on the physiochemical properties of the AMD, namely: pH, redox potential (ORP), conductivity, total dissolved solids (TDS), and dissolved oxygen (DO). © 2020 IOP Publishing Ltd
Integrin-Linked Kinase Expression in Myeloid Cells Promotes Inflammatory Signaling during Experimental Colitis
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
Drugs that target the Renin-Angiotensin System (RAS) have recently come into focus for their potential utility as cancer treatments. The use of Angiotensin Receptor Blockers (ARBs) and Angiotensin-Converting Enzyme (ACE) Inhibitors (ACEIs) to manage hypertension in cancer patients is correlated with improved survival outcomes for renal, prostate, breast and small cell lung cancer. Previous studies demonstrate that the Angiotensin Receptor Type I (AT1R) is linked to breast cancer pathogenesis, with unbiased analysis of gene-expression studies identifying significant up-regulation of AGTR1, the gene encoding AT1R in ER+ve/HER2-ve tumors correlating with poor prognosis. However, there is no evidence, so far, of the functional contribution of AT1R to breast tumorigenesis. We explored the potential therapeutic benefit of ARB in a carcinogen-induced mouse model of breast cancer and clarified the mechanisms associated with its success.Mammary tumors were induced with 7,12-dimethylbenz[α]antracene (DMBA) and medroxyprogesterone acetate (MPA) in female wild type mice and the effects of the ARB, Losartan treatment assessed in a preventative setting (n = 15 per group). Tumor histopathology was characterised by immunohistochemistry, real-time qPCR to detect gene expression signatures, and tumor cytokine levels measured with quantitative bioplex assays. AT1R was detected with radiolabelled ligand binding assays in fresh frozen tumor samples.We showed that therapeutic inhibition of AT1R, with Losartan, resulted in a significant reduction in tumor burden; and no mammary tumor incidence in 20% of animals. We observed a significant reduction in tumor progression from DCIS to invasive cancer with Losartan treatment. This was associated with reduced tumor cell proliferation and a significant reduction in IL-6, pSTAT3 and TNFα levels. Analysis of tumor immune cell infiltrates, however, demonstrated no significant differences in the recruitment of lymphocytes or tumour-associated macrophages in Losartan or vehicle-treated mammary tumors.Analysis of AT1R expression with radiolabelled ligand binding assays in human breast cancer biopsies showed high AT1R levels in 30% of invasive ductal carcinomas analysed. Furthermore, analysis of the TCGA database identified that high AT1R expression to be associated with luminal breast cancer subtype.Our in vivo data and analysis of human invasive ductal carcinoma samples identify the AT1R is a potential therapeutic target in breast cancer, with the availability of a range of well-tolerated inhibitors currently used in clinics. We describe a novel signalling pathway critical in breast tumorigenesis, that may provide new therapeutic avenues to complement current treatments
Mechanism and equilibrium modeling of Re and Mo adsorption on a gel type strong base anion resin
© 2017, Pleiades Publishing, Ltd. A static-batch technique was used to demonstrate the adsorption behavior of Re (VII) and Mo ions onto Dowex 21K at equilibrium in single and binary component systems. The single equilibrium adsorption data were modeled through a linear form of four widely used equilibrium isotherm equations. The results indicated that Freundlich and D-R models for Re, and Temkin and D–R isotherms for Mo fitted the obtained data satisfactorily. Binary adsorptions of Re and Mo ions onto Dowex 21K were also analyzed using Extended Langmuir, Modified Langmuir, Extended Freundlich and Langmuir–Freundlich models. The competitive Extended Freundlich model fitted the binary adsorption equilibrium data adequately. Studies on mutual interference effects of Mo ions on Re adsorption capacity indicated that the adsorption of perrhenate ions is always suppressed. In this perspective, the results from EDX studies confirmed the rhenium atom decrease in the simulated Re–Mo adsorption. However, under the studied conditions the affinity of the Dowex 21K for rhenium ions is marginally greater than that of molybdenum ions